Evommune, Inc. (EVMN)Healthcare | Biotechnology | Palo Alto, United States | NYSE
27.45 USD
+0.68
(2.540%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 27.45 Short-term: ★★★☆☆ | Long-term: ★★★★☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:02 a.m. EDT
Caution on near-term momentum: despite strong long-term catalysts (positive Phase 2a trials, strong buy analyst consensus, robust balance sheet), the short-term price forecast model predicts a -1.97% drift over the next 45 days, suggesting recent rally is due for a technical pullback before the next major catalyst. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.220795 |
| AutoETS | 0.233839 |
| AutoTheta | 0.233850 |
| AutoARIMA | 0.267625 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 79% |
| H-stat | 0.66 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.204 |
| Excess Kurtosis | 0.29 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.002 |
| Revenue per Share | 2.118 |
| Market Cap | 988,704,320 |
| Forward P/E | -8.15 |
| Website | https://www.evommune.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.3568957 |
| Address1 | 1,841 Page Mill Road |
| Address2 | Suite 100 |
| All Time High | 33.2 |
| All Time Low | 13.885 |
| Ask | 27.32 |
| Ask Size | 500 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 294,120 |
| Average Daily Volume3 Month | 617,358 |
| Average Volume | 617,358 |
| Average Volume10Days | 294,120 |
| Bid | 27.16 |
| Bid Size | 300 |
| Book Value | 6.521 |
| City | Palo Alto |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 27.45 |
| Current Ratio | 8.57 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 28.0 |
| Day Low | 26.9 |
| Debt To Equity | 1.002 |
| Display Name | Evommune |
| Earnings Timestamp | 1,772,744,400 |
| Earnings Timestamp End | 1,778,788,800 |
| Earnings Timestamp Start | 1,778,788,800 |
| Ebitda | -79,682,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -10.562 |
| Enterprise To Revenue | 64.736 |
| Enterprise Value | 841,564,288 |
| Eps Current Year | -3.2125 |
| Eps Forward | -3.36714 |
| Eps Trailing Twelve Months | -11.22 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 25.1306 |
| Fifty Day Average Change | 2.3194008 |
| Fifty Day Average Change Percent | 0.09229389 |
| Fifty Two Week Change Percent | 35.689568 |
| Fifty Two Week High | 33.2 |
| Fifty Two Week High Change | -5.75 |
| Fifty Two Week High Change Percent | -0.17319277 |
| Fifty Two Week Low | 13.885 |
| Fifty Two Week Low Change | 13.565001 |
| Fifty Two Week Low Change Percent | 0.97695357 |
| Fifty Two Week Range | 13.885 - 33.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,762,439,400,000 |
| Float Shares | 19,596,516 |
| Forward Eps | -3.36714 |
| Forward P E | -8.152319 |
| Free Cashflow | -56,167,752 |
| Full Exchange Name | NYSE |
| Full Time Employees | 48 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 13,000,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07242 |
| Held Percent Institutions | 0.91729 |
| Implied Shares Outstanding | 36,018,372 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California. |
| Market | us_market |
| Market Cap | 988,704,320 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_695398216 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -68,870,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 988,704,311 |
| Number Of Analyst Opinions | 7 |
| Open | 27.38 |
| Operating Cashflow | -76,441,000 |
| Operating Margins | -6.23623 |
| Payout Ratio | 0.0 |
| Phone | (925) 247-4481 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 27.45 |
| Post Market Time | 1,776,464,120 |
| Previous Close | 26.77 |
| Price Eps Current Year | -8.544747 |
| Price Hint | 2 |
| Price To Book | 4.2094774 |
| Price To Sales Trailing12 Months | 76.05418 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.331 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.22222 |
| Region | US |
| Regular Market Change | 0.68 |
| Regular Market Change Percent | 2.54016 |
| Regular Market Day High | 28.0 |
| Regular Market Day Low | 26.9 |
| Regular Market Day Range | 26.9 - 28.0 |
| Regular Market Open | 27.38 |
| Regular Market Previous Close | 26.77 |
| Regular Market Price | 27.45 |
| Regular Market Time | 1,776,456,003 |
| Regular Market Volume | 211,799 |
| Return On Assets | -0.33667 |
| Return On Equity | -0.5442 |
| Revenue Per Share | 2.118 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 36,018,372 |
| Shares Percent Shares Out | 0.091800004 |
| Shares Short | 3,307,897 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 3,026,153 |
| Short Name | Evommune, Inc. |
| Short Percent Of Float | 0.100600004 |
| Short Ratio | 10.5 |
| Source Interval | 15 |
| State | CA |
| Symbol | EVMN |
| Target High Price | 55.0 |
| Target Low Price | 48.0 |
| Target Mean Price | 51.57143 |
| Target Median Price | 52.0 |
| Total Cash | 149,200,000 |
| Total Cash Per Share | 4.142 |
| Total Debt | 2,060,000 |
| Total Revenue | 13,000,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -11.22 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 21.661802 |
| Two Hundred Day Average Change | 5.7881985 |
| Two Hundred Day Average Change Percent | 0.26720762 |
| Type Disp | Equity |
| Volume | 211,799 |
| Website | https://www.evommune.com |
| Zip | 94,304 |